Tegafur–uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle

OBJECTIVE: The objective of this study was to evaluate the safety of using tegafur–uracil (UFT) in colorectal cancer patients with partial dihydropyrimidine dehydrogenase (DPD) deficiency. PATIENTS AND METHODS: The study included five colorectal cancer patients who presented with acute toxicity (gra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cubero, Daniel I.G., Cruz, Felipe Melo, Santi, Patrícia, Silva, Ismael Dale C.G., del Giglio, Auro
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2012
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384092/
https://ncbi.nlm.nih.gov/pubmed/22754590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012441049
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares